Psychedelic Rx: Legal battles aim to expand patients’ access to psilocybin and other hallucinogens

AIMS Institute’s work with Right-To-Try access to psilocybin for its patients is covered in a feature story in the August 2022 issue of the ABA Journal, the flagship publication of the American Bar Association.